Healthcare provider profile · identity verified

Jesse John Susa, MD

Family Practice · BLACK RIVER FALLS, WI · NPI 1477901395

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	465	124
Metoprolol Succinate	Metoprolol Succinate	240	75
Lisinopril	Lisinopril	230	71
Rosuvastatin Calcium	Rosuvastatin Calcium	221	62
Losartan Potassium	Losartan Potassium	217	57
Amlodipine Besylate	Amlodipine Besylate	214	67
Omeprazole	Omeprazole	210	57
Eliquis	Apixaban	197	35
Metformin Hcl	Metformin Hcl	193	56
Furosemide	Furosemide	168	49
Levothyroxine Sodium	Levothyroxine Sodium	167	49
Tamsulosin Hcl	Tamsulosin Hcl	164	50
Warfarin Sodium	Warfarin Sodium	159	31
Simvastatin	Simvastatin	155	45
Metoprolol Tartrate	Metoprolol Tartrate	154	44
Trulicity	Dulaglutide	140	21
Gabapentin	Gabapentin	118	45
Pantoprazole Sodium	Pantoprazole Sodium	101	28
Trazodone Hcl	Trazodone Hcl	91	21
Irbesartan	Irbesartan	89	26
Duloxetine Hcl	Duloxetine Hcl	87	18
Hydrochlorothiazide	Hydrochlorothiazide	87	29
Carvedilol	Carvedilol	79	21
Potassium Chloride	Potassium Chloride	79	22
Clopidogrel	Clopidogrel Bisulfate	78	20
Tramadol Hcl	Tramadol Hcl	73	14
Bupropion Xl	Bupropion Hcl	71	14
Indapamide	Indapamide	71	23
Jardiance	Empagliflozin	71	13
Spironolactone	Spironolactone	68	14
Allopurinol	Allopurinol	62	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	15
Albuterol Sulfate Hfa	Albuterol Sulfate	56	31
Finasteride	Finasteride	56	14
Escitalopram Oxalate	Escitalopram Oxalate	53	13
Fluticasone Propionate	Fluticasone Propionate	51	24
Prednisone	Prednisone	50	26
Sertraline Hcl	Sertraline Hcl	50	18
Enalapril Maleate	Enalapril Maleate	47	12
Mirtazapine	Mirtazapine	45	12
Xarelto	Rivaroxaban	43	suppressed
Alendronate Sodium	Alendronate Sodium	41	11
Chlorthalidone	Chlorthalidone	40	13
Farxiga	Dapagliflozin Propanediol	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	12
Lovastatin	Lovastatin	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Torsemide	Torsemide	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	15
Glipizide	Glipizide	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	12
Doxycycline Monohydrate	Doxycycline Monohydrate	25	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Ozempic	Semaglutide	21	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Phenytoin	Phenytoin	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Bumetanide	Bumetanide	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Desmopressin Acetate	Desmopressin Acetate	19	suppressed
Digoxin	Digoxin	19	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Azithromycin	Azithromycin	18	suppressed
Baclofen	Baclofen	18	suppressed
Bydureon Bcise	Exenatide Microspheres	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Nitroglycerin	Nitroglycerin	18	15
Nystatin	Nystatin	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Lactulose	Lactulose	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Famotidine	Famotidine	14	suppressed
Topiramate	Topiramate	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Valsartan	Valsartan	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error